These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26712402)

  • 1. [Diagnose pituitary adenoma using dynamic enhanced MRI: a quantitative approach].
    Zheng W; Zhai J; Chen Y
    Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(23):1837-41. PubMed ID: 26712402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging.
    Zhai J; Zheng W; Zhang Q; Wu J; Zhang X
    Oncol Lett; 2019 May; 17(5):4237-4244. PubMed ID: 30944618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma.
    Kamimura K; Nakajo M; Yoneyama T; Bohara M; Nakanosono R; Fujio S; Iwanaga T; Nickel MD; Imai H; Fukukura Y; Yoshiura T
    Jpn J Radiol; 2020 Jul; 38(7):649-657. PubMed ID: 32162178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
    Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
    Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
    Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
    Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
    Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
    Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis.
    Maijer KI; van der Leij C; de Hair MJ; Tas SW; Maas M; Gerlag DM; Tak PP; Lavini C
    Arthritis Rheumatol; 2016 Mar; 68(3):587-96. PubMed ID: 26473331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.
    Zhao W; Quan Z; Huang X; Ren J; Wen D; Zhang G; Shi Z; Yin H; Huan Y
    Oncol Lett; 2018 Jun; 15(6):8349-8356. PubMed ID: 29805568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
    Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of dynamic-contrast enhanced magnetic resonance pharmacokinetic models in differential diagnosis of cellular uterine leiomyoma].
    Wang S; Zhao Z; Hu H; Yang J; Zhao L; Yang L; Wang C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):498-504. PubMed ID: 29488716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer.
    Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G
    Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.